Lamassu Pharma: US FDA grants approval for clinical trials of Lamassu Biotech's cancer treatment protocol
More hope for successfully combating some of the deadliest cancers. Lamassu Biotech is proud to announce its pioneering effort to combat locally advanced metastatic p53 wild─type tumors has earned
Read full article »
Lamassu Pharma is a North Carolina-based biotechnology company that researches and develops small-molecule therapeutics for the treatment of acute pancreatitis.
Read more